Publications by authors named "Maxime P Look"

Claim this Profile
I
Individual participant data meta-analysis for external validation, recalibration, and updating of a flexible parametric prognostic model.
Joie Ensor, Kym I E Snell, Thomas P A Debray, Paul C Lambert, Maxime P Look

Stat Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer.
Yinghui Zhang, Lynn Wester, Jichao He, Tamar Geiger, Marja Moerkens, Maxime P Look

Oncogene· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
Simone U Dalm, Willemijne A M E Schrijver, Anieta M Sieuwerts, Maxime P Look, Angelique C J Ziel-van der Made

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
Jingjing Liu, Anieta M Sieuwerts, Maxime P Look, Michelle van der Vlugt-Daane, Marion E Meijer-van Gelder

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.
Tommaso De Marchi, Mieke A Timmermans, Anieta M Sieuwerts, Marcel Smid, Maxime P Look

Sci Rep· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
Lisanne F van Dessel, Nick Beije, Jean C A Helmijr, Silvia R Vitale, Jaco Kraan, Maxime P Look

Mol Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.
Diana E Ramirez-Ardila, Kirsten Ruigrok-Ritstier, Jean C Helmijr, Maxime P Look, Steven van Laere

Mol Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid treatment failure in cancer patients: the role of clinical and genetic factors.
Astrid W Oosten, Maja Matic, Ron H van Schaik, Maxime P Look, Joost L Jongen

Pharmacogenomics· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Ning Qing Liu, Tommaso De Marchi, Annemieke Timmermans, Anita M A C Trapman-Jansen, Renée Foekens, Maxime P Look

Sci Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
Jingjing Liu, Wendy J C Prager-van der Smissen, Maxime P Look, Anieta M Sieuwerts, Marcel Smid

Cancer Lett· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis.
Marjolein J A Weerts, Anieta M Sieuwerts, Marcel Smid, Maxime P Look, John A Foekens

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy.
Kimberly D van der Willik, Mieke M Timmermans, Carolien Hm van Deurzen, Maxime P Look, Esther A Reijm

Am J Cancer Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model.
Kym I E Snell, Harry Hua, Thomas P A Debray, Joie Ensor, Maxime P Look

J Clin Epidemiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
Tommaso De Marchi, Ning Qing Liu, Cristoph Stingl, Mieke A Timmermans, Marcel Smid, Maxime P Look

Mol Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancer.
Tommaso De Marchi, Anne M Timmermans, Marcel Smid, Maxime P Look, Christoph Stingl

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy.
Simone U Dalm, Anieta M Sieuwerts, Maxime P Look, Marleen Melis, Carolien H M van Deurzen

J Nucl Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
Wies van Roosmalen, Sylvia E Le Dévédec, Ofra Golani, Marcel Smid, Irina Pulyakhina, Maxime P Look

J Clin Invest· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers.
Anieta M Sieuwerts, Scooter Willis, Michael B Burns, Maxime P Look, Marion E Meijer-Van Gelder

Horm Cancer· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth and metastatic behavior of molecularly well-characterized human breast cancer cell lines in mice.
Muhammad Riaz, Buddy Setyono-Han, Mieke A Timmermans, Anita M Trapman, Joan Bolt-de Vries, Maxime P Look

Breast Cancer Res Treat· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis.
Michael J Crowther, Maxime P Look, Richard D Riley

Stat Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response.
Ning Qing Liu, Tommaso De Marchi, Annemieke M Timmermans, Robin Beekhof, Anita M A C Trapman-Jansen, Maxime P Look

Mol Cell Proteomics· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
Ning Qing Liu, Christoph Stingl, Maxime P Look, Marcel Smid, René B H Braakman

J Natl Cancer Inst· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.
Anika Nagelkerke, Anieta M Sieuwerts, Johan Bussink, Fred C G J Sweep, Maxime P Look

Endocr Relat Cancer· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations.
Roxana S Redis, Anieta M Sieuwerts, Maxime P Look, Oana Tudoran, Cristina Ivan

Oncotarget· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen.
Diana E Ramirez-Ardila, Jean C Helmijr, Maxime P Look, Irene Lurkin, Kirsten Ruigrok-Ritstier

Breast Cancer Res Treat· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis